Supporters: 2019
We are pleased to confirm At the Limits events are sponsored by various Industry partners.
In 2019 this includes Sponsorship and Grants confirmed as follows, with a number of other sponsorship agreements awaiting confirmation and once finalised they will appear here.
Sponsors have not influenced the content or the speaker selection of the independent programmes, nor had, or will have foresight of the presentations.
DELEGATE SOURCING
At The Limits will use a multi-channel approach to source the delegates to invite to attend the meeting. Please note that it should not be necessary that all of these channels are used, participants are referred into the programme from one or more channels.
Typical channels include;
- Professional Societies (Global, Regional, Local)
- Ministries of Health
- Universities and Medical Colleges
- Promotion by programme faculty or independent steering committees assembled by ATL
- Advertisement in Peer Reviewed Publications
- Advertisements in paid media (e.g. Google Ads)
- Free Social Media Advertisement (e.g. Facebook)
- Promotion by At The Limits at relevant congresses and symposia (e.g. ECO)
- Promotion by At The Limits to learners in their HCP database
- Promotion by Commercial Supporters via affiliates
- Referral by At The Limits alumni (other learners sharing information about the programme with peers
This activity has been supported by a sponsorship from Roche Products Limited. Roche Products Limited has had no control over the educational content of this activity.
Novo Nordisk A/S has supported this International meeting through sponsorship, and has had no control or input into the educational content of this activity, nor the logistics functions, ie Travel, Accommodation, Catering or Venues selection.
Servier has supported this International meeting through financial sponsorship and has had no control or input into the educational content of this activity, nor the logistics elements, ie travel, accommodation, catering, venue selection or any other aspect of the meeting. Servier is an independent international pharmaceutical company governed by a non-profit foundation. With a strong international presence in 149 countries and a turnover of 4.152 billion euros in 2017, Servier employs 21,700 people and reinvests 25% of its turnover (princeps drugs) in R&D. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric diseases, cancer and diabetes, as well as by its activities in high-quality generic drugs.
Brazil
Novo Nordisk A/S has supported this International meeting through sponsorship, and has had no control or input into the educational content of this activity, nor the logistics functions, ie Travel, Accommodation, Catering or Venues selection.